Respiratory syncytial virus (Formulary)

PALIVIZUMAB

Important: Therapy notes

  • For use in paediatrics only.

Important: Formulation and dosage details

Formulation:

Injection 50mg/0·5mL, 100mg/1mL (s)

Editorial Information

Document Id: F286